Covidien’s Pipeline, NovoCure’s NovoTFF Set For FDA Panel Review
This article was originally published in The Gray Sheet
Executive Summary
FDA’s Neurological Devices panel is set to review Covidien’s Pipeline embolization device and NovoCure’s NovoTFF-100A brain tumor treatment kit during a March 17-18 meeting.
You may also be interested in...
Covidien’s Pipeline Gains Unanimous Panel Endorsement For Large Aneurysms
FDA’s Neurological Devices Panel unanimously endorsed safety and efficacy data on Covidien’s Pipeline aneurysm embolization device March 18.
Covidien’s Pipeline Gains Unanimous Panel Endorsement For Large Aneurysms
FDA’s Neurological Devices Panel unanimously endorsed safety and efficacy data on Covidien’s Pipeline aneurysm embolization device March 18.
Research In Brief
Covidien hernia repair